Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of genetic testing that has the advantage of being able to screen all the genes in a person. Currently it is mainly being used for research purposes. The purpose of this prospective study is to find out whether genomic sequencing offers value for money when used in the clinical setting to help diagnose people with epilepsy.
Central Clinical School
Masters by Research